Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NO-COVER: iNO for COVID-19 and Hypoxemia
NCT04398290Phase 2Withdrawn
- Start
- Dec 2020
- Primary completion
- Jun 2021
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in coronavirus disease 2019 (COVID-19). Planned start Dec 2020; status: withdrawn.
02
Drugs
nitric oxide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04398290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04398290.